Deloitte Releases 12th Annual Life Sciences Industry Accounting Guide
Report provides comprehensive look at financial and accounting issues faced by life sciences industry.
On Mar. 16 Deloitte released its 12th annual Life Sciences Industry Accounting Guide. The report provides a comprehensive look at some of the complex issues that finance and accounting professionals in the life sciences industry face including R&D costs, acquisitions and divestitures, consolidation, contingencies, revenue recognition, income taxes, financial instruments, and financial statement presentation and disclosure.
Some of the main themes from this year’s edition include:
- COVID-19-Related Accounting and Financial Reporting Considerations for Life Sciences Entities
- IPOs and SPACs
- Revenue Recognition
- Structured Trade Payable Arrangement
For additional information and the full report, click here.
Novo Nordisk, The United Laboratories Ink Exclusive License Agreement for Triple Receptor Agonist
March 25th 2025Under terms of the license agreement, Novo Nordisk will acquire the rights to develop and commercialize UBT251 outside of China for obesity and type 2 diabetes for an upfront payment of $200 million.
